From predictions to prescriptions: A data-driven response to COVID-19

被引:0
作者
Dimitris Bertsimas
Leonard Boussioux
Ryan Cory-Wright
Arthur Delarue
Vassilis Digalakis
Alexandre Jacquillat
Driss Lahlou Kitane
Galit Lukin
Michael Li
Luca Mingardi
Omid Nohadani
Agni Orfanoudaki
Theodore Papalexopoulos
Ivan Paskov
Jean Pauphilet
Omar Skali Lami
Bartolomeo Stellato
Hamza Tazi Bouardi
Kimberly Villalobos Carballo
Holly Wiberg
Cynthia Zeng
机构
[1] Massachusetts Institute of Technology,Sloan School of Management
[2] Massachusetts Institute of Technology,Operations Research Center
[3] Benefits Science Technologies,undefined
[4] London Business School,undefined
[5] Operations Research and Financial EngineeringPrinceton University,undefined
来源
Health Care Management Science | 2021年 / 24卷
关键词
COVID-19; Epidemiological modeling; Machine learning; Optimization;
D O I
暂无
中图分类号
学科分类号
摘要
The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We design analytical tools to support these decisions and combat the pandemic. Specifically, we propose a comprehensive data-driven approach to understand the clinical characteristics of COVID-19, predict its mortality, forecast its evolution, and ultimately alleviate its impact. By leveraging cohort-level clinical data, patient-level hospital data, and census-level epidemiological data, we develop an integrated four-step approach, combining descriptive, predictive and prescriptive analytics. First, we aggregate hundreds of clinical studies into the most comprehensive database on COVID-19 to paint a new macroscopic picture of the disease. Second, we build personalized calculators to predict the risk of infection and mortality as a function of demographics, symptoms, comorbidities, and lab values. Third, we develop a novel epidemiological model to project the pandemic’s spread and inform social distancing policies. Fourth, we propose an optimization model to re-allocate ventilators and alleviate shortages. Our results have been used at the clinical level by several hospitals to triage patients, guide care management, plan ICU capacity, and re-distribute ventilators. At the policy level, they are currently supporting safe back-to-work policies at a major institution and vaccine trial location planning at Janssen Pharmaceuticals, and have been integrated into the US Center for Disease Control’s pandemic forecast.
引用
收藏
页码:253 / 272
页数:19
相关论文
共 101 条
  • [1] Anderson RM(2020)How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet 395 931-934
  • [2] Heesterbeek H(2016)The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia Intensive Care Med 42 699-711
  • [3] Klinkenberg D(2000)A trust region method based on interior point techniques for nonlinear programming Math Program 89 149-185
  • [4] Hollingsworth TD(2013)Effects of prone positioning on lung protection in patients with acute respiratory distress syndrome Am J Respir Crit Care Med 188 440-448
  • [5] Bein T(2020)Phylogenetic network analysis of SARS-CoV-2 genomes Proc Natl Acad Sci 117 9241-9243
  • [6] Grasso S(2020)Clinical characteristics of coronavirus disease 2019 in china New Engl J Med 382 1708-1720
  • [7] Moerer O(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 497-506
  • [8] Quintel M(2017)Stockpiling ventilators for influenza pandemics Emerg Infect Dis 23 914-147
  • [9] Guerin C(1998)Convergence properties of the Nelder–Mead simplex method in low dimensions SIAM J Optim 9 112-1503
  • [10] Deja M(2020)Positive RT-PCR test results in patients recovered from COVID-19 JAMA 323 1502-5839